Get Started

LXRX

NASD Lexicon Pharmaceuticals, Inc.
Nov 4, 2026 · 8:30 AM ET LAST TRADE Market Closed

$1.48 ↑ +0.02 (+1.18%) Trading Up from the previous close of $1.46

YTD change
+28.45%
vs 20-day SMA
-4.83%
vs 200-day SMA
-21.67%

Price ranges

Previous day
$1.44 $1.52
open $1.45 close $1.46
+$0.01 (+0.69%)
Today
$0.00 $0.00
$1.48
Past week
$1.38 $1.52
from $1.48 now $1.48
-$0.00 (-0.19%)
Past month
$1.37 $1.78
from $1.75 now $1.48
-$0.27 (-15.59%)
This year
$1.10 $2.68
from $1.15 now $1.48
+$0.33 (+28.45%)

Price & Performance

-0.14 (-8.75%) / 6M

$1.32$1.79$2.27$2.74May 4Aug 4Nov 3

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 91.8% away from all-time highs of $18.00
  • LXRX is up 28% since the beginning of the year
  • LXRX is up 11% over the past 12 months
  • LXRX is down 16% over the past 1 month
  • 11% of all LXRX investors are betting against LXRX

LXRX reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +9.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.07
Earnings momentum -23.9% Quarterly EPS growth
Quarterly change -23.9%

Valuation

P/E ratio N/A
Enterprise value $507.6M
Beta 0.85

Balance sheet & scale

IncomeN/A
Revenue$41.5M
Cash$190.6M
Debt$59.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $657.3M

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,409.38 -0.11%
JNJ Johnson & Johnson $266.17 -1.62%
ABBV AbbVie, Inc. $286.00 -0.98%
MRK Merck & Co., Inc. $144.67 -2.49%
RHHVF Roche Holding Ltd $481.54 -0.71%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.